Form 10-Q · Quarterly report
Moody's Corporation 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0001059556
- Accession no.
- 0001628280-26-049398
Summary
Moody's Corporation reported second-quarter 2026 revenue of $2.185 billion, up 15% from a year earlier, and net income attributable to Moody's of $878 million, or $5.03 diluted EPS. The results included 25% external revenue growth at Moody's Investors Service and a $181 million gain on the divestiture of the MA Regulatory Solutions business.
Key points
- Total revenue rose 15% year over year to $2.185 billion, with MIS external revenue up 25% and MA external revenue up 4%.
- Operating margin expanded to 47.9% from 43.1%, and adjusted operating margin expanded to 55.3% from 50.9%.
- Diluted EPS increased 57% to $5.03, and adjusted diluted EPS rose 31% to $4.68.
- Moody's Analytics growth was driven by insurance and KYC solutions, while banking revenue declined 14%, partly due to the MA Learning Solutions and MA Regulatory Solutions divestitures.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion RESULTS OF OPERATIONS The following footnotes are applicable throughout the discussion of the Company's results of operations: (1) Refer to the section entitled "Non-GAAP Financial Measures" of this MD&A for the definition and methodology that the Company utilizes to calculate this metric. (2) Refer to the section entitled "Key Performance Metrics" of this MD&A for the definition and methodology that the Company utilizes to calculate this metric. Three months ended June 30, 2026 compared with three months ended June 30, 2025 Executive Summary The following table provides an executive summary of key operating results for the quarter ended June 30, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.